NexGel, Inc (NXGL)
Nasdaq: NXGL · Surgical & Medical Instruments & Apparatus · Langhorne, PA · filing with the SEC since 2009
Who owns NexGel, Inc
As filed with the SECHolders of 5% or more
1
Asymmetry Point LP holds 8.8% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G/A filed Apr 29, 2026 says.
Directors and officers
6
report now, of 15 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Asymmetry Point LP
SCHEDULE 13G/A · filed Apr 29, 2026 · Common Stock, par value $0.001 per share · 7.49% in Mar 12, 2026
What NXGL reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Cgnjv
An entity · consolidated entity · owns, named in the 10-K filed Mar 31, 2026
Nex Gel
An entity · consolidated entity · owns, named in the 10-K filed Mar 31, 2026
Enigma Health Joint Venture
A company bought · acquisition · owns, named in the 10-K filed Mar 31, 2026
2 subsidiaries in 1 country, from the list filed with the 10-K filed Mar 31, 2026.
Insider tradesForm 4
16sales
0purchases
5sales on a scheduled plan
2people selling
$100,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 17 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Levy Adam R. | Chief Executive Officer | 14 | $100,000 | 3 | 0 | $0 |
| Henry Scott Robert | director | 2 | $0 | 2 | 0 | $0 |